Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 2.44%610.52M | -10.21%368.3M | -27.07%136.69M | 19.37%843.17M | 7.07%595.97M | 10.03%410.2M | 13.74%187.43M | 3.37%706.33M | 14.17%556.63M | 13.08%372.8M |
| Refunds of taxes and levies | -19.36%415.75K | -19.36%415.75K | --415.75K | -95.65%515.55K | -66.25%515.55K | -33.99%515.55K | ---- | 452.55%11.84M | -28.72%1.53M | -63.56%781.05K |
| Net deposit increase | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Net increase in borrowings from central bank | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Net increase in placements from other financial institutions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash received from interests, fees and commissions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Net increase in repurchase business capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Premiums received from original insurance contracts | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Net cash received from reinsurance business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Net increase in deposits from policyholders | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Net increase in funds disbursed | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Net cash received from trading securities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash received relating to other operating activities | -24.81%9.2M | 10.24%7.52M | -43.34%2.86M | 62.63%23.95M | -48.66%12.24M | -23.12%6.82M | -24.74%5.05M | -44.10%14.73M | -8.41%23.83M | -56.44%8.87M |
| Cash inflows from operating activities | 1.87%620.13M | -9.89%376.24M | -27.28%139.97M | 18.38%867.63M | 4.59%608.72M | 9.17%417.54M | 11.72%192.48M | 2.97%732.89M | 12.85%582M | 8.59%382.45M |
| Goods services cash paid | -14.25%439.94M | -11.31%283.52M | -5.09%135.93M | 16.14%616.04M | 36.18%513.02M | 50.69%319.69M | 24.33%143.21M | 1.32%530.41M | 4.70%376.73M | -0.80%212.16M |
| Staff behalf paid | 30.68%161.01M | 34.52%104.51M | 58.32%51.58M | 47.41%166.49M | 50.65%123.21M | 50.37%77.69M | 31.66%32.58M | 13.40%112.94M | 7.65%81.79M | -6.01%51.66M |
| All taxes paid | -2.66%38.93M | 22.65%28.56M | 3.28%12.26M | 50.67%56.79M | 26.15%39.99M | 3.19%23.29M | 100.04%11.88M | 31.12%37.69M | 30.29%31.7M | 123.28%22.57M |
| Net loan and advance increase | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Net deposit in central bank and institutions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Net lend capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash paid for fees and commissions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash paid for indemnity of original insurance contract | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Policy dividend cash paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash paid relating to other operating activities | 31.56%36.37M | 64.49%29.09M | 29.10%10.75M | 96.94%42.55M | 10.01%27.64M | -9.29%17.69M | 126.28%8.32M | -16.77%21.61M | 29.41%25.13M | 15.61%19.5M |
| Cash outflows from operating activities | -3.92%676.25M | 1.67%445.68M | 7.41%210.52M | 25.51%881.87M | 36.58%703.87M | 43.31%438.35M | 31.05%195.99M | 3.66%702.65M | 7.47%515.35M | 3.41%305.88M |
| Net cash flows from operating activities | 41.02%-56.12M | -233.63%-69.44M | -1,908.66%-70.56M | -147.07%-14.24M | -242.76%-95.15M | -127.18%-20.81M | -115.45%-3.51M | -10.91%30.24M | 84.24%66.65M | 35.78%76.57M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -20.02%925.02M | 0.68%706.46M | -56.08%130M | 60.63%1.45B | 126.77%1.16B | --701.66M | --295.96M | 502.06%903.09M | 272.29%510.03M | ---- |
| Cash received from returns on investments | 82.95%24.85M | 247.93%22.35M | 217.36%3.57M | 1,758.55%20.63M | 14,076.25%13.58M | --6.42M | --1.12M | 542.07%1.11M | -37.51%95.81K | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -78.02%165.75K | -91.09%58.32K | -90.67%45.32K | 84.67%1.14M | 331.57%754.16K | 828.63%654.31K | --486K | 854.57%614.75K | 2,469.79%174.75K | 3,814.44%70.46K |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash received relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash inflows from investing activities | -18.86%950.04M | 2.84%728.87M | -55.10%133.61M | 62.73%1.47B | 129.46%1.17B | 1,005,771.52%708.74M | --297.57M | 502.26%904.81M | 272.05%510.3M | -99.89%70.46K |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -35.24%184.87M | -8.63%150.87M | 35.50%120.23M | 130.38%326.26M | 655.76%285.49M | 1,345.29%165.12M | 5,129.82%88.74M | 137.86%141.62M | -14.51%37.77M | -68.33%11.42M |
| Cash paid to acquire investments | -61.79%541.43M | -62.85%440.93M | -56.37%280.12M | -6.81%1.59B | 100.70%1.42B | --1.19B | --641.96M | 1,040.65%1.71B | 404.31%706.03M | ---- |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Impawned loan net increase | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash outflows from investing activities | -57.34%726.3M | -56.23%591.8M | -45.21%400.35M | 3.68%1.92B | 128.89%1.7B | 11,734.15%1.35B | 42,964.90%730.69M | 784.13%1.85B | 303.83%743.81M | -88.35%11.42M |
| Net cash flows from investing activities | 142.09%223.74M | 121.31%137.08M | 38.41%-266.74M | 52.69%-448.39M | -127.65%-531.58M | -5,565.63%-643.3M | -25,426.98%-433.12M | -1,498.23%-947.78M | -396.52%-233.5M | 68.47%-11.35M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --739.45M | --739.45M | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash from borrowing | -29.21%654.18M | -43.06%449.27M | -31.30%449.27M | 150.48%924.06M | 243.62%924.06M | 258.74%789M | 588.42%654M | 78.96%368.92M | 64.48%268.92M | 48.11%219.94M |
| Cash received relating to other financing activities | 74.99%298.35M | 61.57%211.19M | 2,000.27%204.54M | 6.54%353.6M | 133.96%170.49M | --130.71M | --9.74M | 690.21%331.89M | 127.73%72.87M | ---- |
| Cash inflows from financing activities | -12.98%952.53M | -28.19%660.46M | -1.50%653.81M | -11.29%1.28B | 1.23%1.09B | 318.17%919.71M | 598.67%663.74M | 480.41%1.44B | 453.07%1.08B | 48.11%219.94M |
| Borrowing repayment | 157.42%763M | 355.73%526M | 835.54%290M | 201.36%562M | 68.92%296.4M | 3.85%115.42M | -38.00%31M | 24.32%186.49M | 34.97%175.47M | 58.78%111.15M |
| Dividend interest payment | -1.99%31.72M | 7.35%28.93M | 6.50%3.97M | 86.89%59.89M | 6.97%32.37M | 974.78%26.95M | 227.47%3.73M | 80.80%32.04M | 80.64%30.26M | -83.81%2.51M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash payments relating to other financing activities | 11.48%321.59M | -25.35%213.94M | -76.15%26.45M | 907.18%388.22M | 289.56%288.47M | 2,361.94%286.61M | 1,642.86%110.89M | -38.19%38.54M | 3.47%74.05M | -78.71%11.64M |
| Cash outflows from financing activities | 80.86%1.12B | 79.23%768.87M | 120.05%320.42M | 292.92%1.01B | 120.62%617.24M | 242.37%428.98M | 153.24%145.61M | 11.73%257.08M | 28.15%279.77M | -10.61%125.3M |
| Net cash flows from financing activities | -134.31%-163.78M | -122.09%-108.41M | -35.65%333.39M | -77.39%267.57M | -40.44%477.32M | 418.51%490.74M | 1,281.68%518.13M | 6,451.81%1.18B | 3,612.76%801.47M | 1,035.17%94.64M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 4.24%1.1M | 23.69%964.46K | 44.95%508.47K | 36.80%1.02M | 105.95%1.06M | 16.83%779.75K | 207.34%350.78K | 373.50%746.35K | 1,544.03%514.29K | 470.09%667.45K |
| Net increase in cash and cash equivalents | 103.33%4.95M | 76.93%-39.81M | -104.15%-3.4M | -172.84%-194.04M | -123.36%-148.35M | -207.52%-172.6M | 40.61%81.84M | 3,831.90%266.39M | 1,988.15%635.13M | 462.58%160.53M |
| Add:Begin period cash and cash equivalents | -62.21%117.86M | -62.21%117.86M | -62.21%117.86M | 585.44%311.9M | 585.44%311.9M | 585.44%311.9M | 585.44%311.9M | -13.56%45.5M | -13.56%45.5M | -13.56%45.5M |
| End period cash equivalent | -24.91%122.8M | -43.97%78.04M | -70.93%114.46M | -62.21%117.86M | -75.97%163.55M | -32.39%139.3M | 279.66%393.74M | 585.44%311.9M | 3,481.58%680.64M | 153.81%206.03M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.